The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision supportAnja Irmisch, Martina Haberecker, Rebekka Wegmann et al.|Cancer Cell|2021Cited by 140
Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cellsPatrick Imesch, André Fedier|Fertility and Sterility|2010Cited by 46
The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cellsAndré Fedier, Daniel Fink|International Journal of Oncology|2007Cited by 37
MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cellsAndré Fedier|International Journal of Oncology|2009Cited by 10
Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell linesAndré Fedier, Viola Heinzelmann‐Schwarz|International Journal of Oncology|2022Cited by 9